| abstract |
This invention relates to suspensions for oral administration comprising novelntrovafloxacin zwitterionic crystals, and processes for preparing such crystals. Thisninvention further relates to other pharmaceutical compositions comprising these novelncrystals, and to methods of using these suspensions, and these novel crystals in suchnother dosage forms, for treating bacterial infections in mammals. |